Neoplasms News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

VETERINARY VIEWPOINTS: Cancer and pets - Stillwater News Press



Stillwater News Press
 
VETERINARY VIEWPOINTS: Cancer and pets 
Stillwater News Press
The growth itself is called a neoplasm or tumor. Tumors can be benign or malignant. Benign neoplasms tend to grow slowly. They displace, but do not invade, surrounding body tissues and do not spread throughout the body. Malignant neoplasms, on the ...

 


Ga-DOTATATE Imaging of Neuroendocrine Neoplasms: Interpretation, Biodistribution, Dosimetry, and Molecular ... - Journal of Nuclear Medicine



Ga-DOTATATE Imaging of Neuroendocrine Neoplasms: Interpretation, Biodistribution, Dosimetry, and Molecular ... 
Journal of Nuclear Medicine
For correspondence or reprints contact: Lisa Bodei, Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave., Box 77, New York, NY 10065. E-mail: bodeil@mskcc.org ...

and more » 


Myeloproliferative Neoplasms Forecast in 12 Major Markets 2017-2027 - USA, Canada, France, Germany, Italy, Spain ... - Business Wire (press release)



Myeloproliferative Neoplasms Forecast in 12 Major Markets 2017-2027 - USA, Canada, France, Germany, Italy, Spain ... 
Business Wire (press release)
Myeloproliferative neoplasms (MPNs) are a group of diseases that concern the clonal proliferation of precursors of the myeloid lineage cells in the bone marrow. MPNs are characterized by uncontrolled cell growth, and therefore can also be classified as ...

and more » 


Epiomic Epidemiology Series: Myeloproliferative Neoplasms Forecast In 12 Major Markets 2017-2027 - PR Newswire (press release)



Epiomic Epidemiology Series: Myeloproliferative Neoplasms Forecast In 12 Major Markets 2017-2027 
PR Newswire (press release)
Myeloproliferative neoplasms (MPNs) are a group of diseases that concern the clonal proliferation of precursors of the myeloid lineage cells in the bone marrow. MPNs are characterized by uncontrolled cell growth, and therefore can also be classified as ...

 


Effective treatment of low-dose decitabine in myelodysplastic syndrome/myeloproliferative neoplasms - Dove Medical Press



Effective treatment of low-dose decitabine in myelodysplastic syndrome/myeloproliferative neoplasms 
Dove Medical Press
Objective: Primary myelofibrosis (PMF) is one of the Philadelphia negative myeloproliferative neoplasms (MPN). The main clinical features are obvious physical symptoms and symptomatic splenomegaly. It may be converse to leukemia and has a shortened ...

 


Cancer through the lens of evolution - Arizona State University



Arizona State University
 
Cancer through the lens of evolution 
Arizona State University
Neoplasms evolve, flourishing or dying away in response to selective pressures. Although this fact has long been appreciated in biology, no formalized system for classifying the evolutionary and ecological characteristics of neoplasms in a clinically ...

 


Evaluation of a fecal immunochemistry test prior to colonoscopy for outpatients with various indications - Dove Medical Press



Evaluation of a fecal immunochemistry test prior to colonoscopy for outpatients with various indications 
Dove Medical Press
Background: Stool tests can predict advanced neoplasms prior to colonoscopy. Results of immunochemical stool tests to predict findings at colonoscopy for various indications are less often reported. We compared pre-colonoscopy stool tests with findings ...

 


Stemline Therapeutics Reports Third Quarter 2017 Financial Results - Markets Insider



Stemline Therapeutics Reports Third Quarter 2017 Financial Results 
Markets Insider
On October 31, 2017, we announced that the pivotal trial of SL-401 in blastic plasmacytoid dendritic cell neoplasm (BPDCN) met its primary endpoint. We anticipate that a Biologics License Application (BLA) submission could begin in the fourth quarter ...

and more » 


Myelofibrosis Market Report 2017 - Research and Markets - Business Wire (press release)



Myelofibrosis Market Report 2017 - Research and Markets 
Business Wire (press release)
The US has a substantial lead in the number of myeloproliferative neoplasms clinical trials globally, yet the forecasted prevalent cases of myelofibrosis are lower in North America as compared with Asia and Europe. Germany leads the major EU markets, ...

and more » 


Stemline Therapeutics Announces that Pivotal Trial of SL-401 in Blastic Plasmacytoid Dendritic Cell Neoplasm ... - GlobeNewswire (press release)



Press Telegraph
 
Stemline Therapeutics Announces that Pivotal Trial of SL-401 in Blastic Plasmacytoid Dendritic Cell Neoplasm ... 
GlobeNewswire (press release)
NEW YORK, Oct. 31, 2017 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical stage biopharmaceutical company developing novel therapeutics for difficult to treat cancers, announced today that the pivotal Phase 2 trial of SL-401 in ...
Stemline Announces Four SL-401 Presentations at Upcoming ASH Meeting Markets Insider

all 106 news articles »